BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Syn NL, Yong WP, Lee SC, Goh BC. Genetic factors affecting drug disposition in Asian cancer patients. Expert Opin Drug Metab Toxicol 2015;11:1879-92. [PMID: 26548636 DOI: 10.1517/17425255.2015.1108964] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Fathi Z, Syn NL, Zhou J, Roudi R. Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention. J Hum Genet 2018;63:783-94. [DOI: 10.1038/s10038-018-0450-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
2 Syn NL, Yong WP, Goh BC, Lee SC. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review. Expert Opin Drug Metab Toxicol 2016;12:911-22. [PMID: 27249175 DOI: 10.1080/17425255.2016.1196187] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
3 Kim TY, Yen C, Al-batran S, Ferry D, Gao L, Hsu Y, Cheng R, Orlando M, Ohtsu A. Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer. Gastric Cancer 2018;21:276-84. [DOI: 10.1007/s10120-017-0737-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
4 Kumarakulasinghe NB, Syn N, Soon YY, Asmat A, Zheng H, Loy EY, Pang B, Soo RA. EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction. Oncotarget 2016;7:85542-50. [PMID: 27907909 DOI: 10.18632/oncotarget.13458] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
5 Bajaj G, Gupta M, Wang HH, Barrett JS, Tan M, Rupalla K, Bertz R, Sheng J. Challenges and Opportunities With Oncology Drug Development in China. Clin Pharmacol Ther 2018;105:363-75. [DOI: 10.1002/cpt.1017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Ghasemi S, Mahaki B, Dreassi E, Aghamohammadi S. Spatial Variation in Lung Cancer Mortality and Related Men-Women Disparities in Iran from 2011 to 2014. Cancer Manag Res 2020;12:4615-24. [PMID: 32606954 DOI: 10.2147/CMAR.S247178] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Heong V, Syn NL, Lee XW, Sapari NS, Koh XQ, Adam Isa ZF, Sy Lim J, Lim D, Pang B, Thian YL, Ng LK, Wong AL, Soo RA, Yong WP, Chee CE, Lee SC, Goh BC, Soong R, Tan DSP. Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study. Int J Cancer 2018;142:1890-900. [PMID: 28994108 DOI: 10.1002/ijc.31091] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
8 Soo RA, Syn N, Lee SC, Wang L, Lim XY, Loh M, Tan SH, Zee YK, Wong AL, Chuah B, Chan D, Lim SE, Goh BC, Soong R, Yong WP. Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours. Sci Rep 2016;6:27826. [PMID: 27296624 DOI: 10.1038/srep27826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Zhang J, Cai J, Bello A, Roy A, Sheng J. Model-Based Population Pharmacokinetic Analysis of Nivolumab in Chinese Patients With Previously Treated Advanced Solid Tumors, Including Non-Small Cell Lung Cancer. J Clin Pharmacol 2019;59:1415-24. [PMID: 31115908 DOI: 10.1002/jcph.1432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Syn N, Lee S, Goh B, Yong W. Capecitabine pharmacogenetics: historical milestones and progress toward clinical implementation. Pharmacogenomics 2016;17:1607-10. [DOI: 10.2217/pgs-2016-0133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Narumiya K, Bollschweiler E, Hölscher AH, Yamamoto M, Drebber U, Alakus H, Metzger R, Warnecke-Eberz U. Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1. Future Oncol 2020;16:2075-87. [PMID: 32611208 DOI: 10.2217/fon-2020-0489] [Reference Citation Analysis]
12 Peng L, Yang LS, Yam P, Lam CS, Chan AS, Li CK, Cheung YT. Neurocognitive and Behavioral Outcomes of Chinese Survivors of Childhood Lymphoblastic Leukemia. Front Oncol 2021;11:655669. [PMID: 33959507 DOI: 10.3389/fonc.2021.655669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Syn NL, Wong AL, Lee SC, Teoh HL, Yip JWL, Seet RC, Yeo WT, Kristanto W, Bee PC, Poon LM, Marban P, Wu TS, Winther MD, Brunham LR, Soong R, Tai BC, Goh BC. Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial. BMC Med 2018;16:104. [PMID: 29986700 DOI: 10.1186/s12916-018-1093-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
14 Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8:CD004064. [PMID: 28850174 DOI: 10.1002/14651858.cd004064.pub4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 166] [Article Influence: 15.4] [Reference Citation Analysis]
15 Poon LHJ, Yu CP, Peng L, Ewig CL, Zhang H, Li CK, Cheung YT. Clinical ascertainment of health outcomes in Asian survivors of childhood cancer: a systematic review. J Cancer Surviv 2019;13:374-96. [PMID: 31055708 DOI: 10.1007/s11764-019-00759-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
16 Abrahão R, Huynh JC, Benjamin DJ, Li QW, Winestone LE, Muffly L, Keegan THM. Chronic medical conditions and late effects after acute myeloid leukaemia in adolescents and young adults: a population-based study. Int J Epidemiol 2021;50:663-74. [PMID: 34000732 DOI: 10.1093/ije/dyaa184] [Reference Citation Analysis]
17 Tan VZZ, Chan NM, Ang WL, Mya SN, Chan MY, Chen CK. Cardiotoxicity After Anthracycline Chemotherapy for Childhood Cancer in a Multiethnic Asian Population. Front Pediatr 2021;9:639603. [PMID: 33614560 DOI: 10.3389/fped.2021.639603] [Reference Citation Analysis]